These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 305416)

  • 1. Friend virus-induced immunodepression: effect of neuraminidase treatment on Thy-1.2 antigen expression and cytotoxic potential of splenocytes from virus-infected mice.
    Mascio AA; Ceglowski WS
    Infect Immun; 1978 Feb; 19(2):486-92. PubMed ID: 305416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
    Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
    Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy of murine leukemia. XI. differential susceptibility of spleen cells from serum-protected mice to the in vitro immunosuppressive effects of Friend leukemia virus-infected splenocytes.
    Pettey CL; Collins JJ
    Int J Cancer; 1984 Aug; 34(2):269-76. PubMed ID: 6540757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte surface receptors and leukemia virus-induced immunosuppression.
    Friedman H; Kateley JR
    Am J Clin Pathol; 1975 May; 63(5):735-47. PubMed ID: 1093386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Friend virus antigen-modulated erythroleukemic cells to lysis by T lymphocytes from mice with dormant Friend virus infections.
    Genovesi EV; Marx PA; Wheelock EF
    J Immunol; 1979 Mar; 122(3):795-800. PubMed ID: 312825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of genetic resistance to Friend virus leukemia. III. Susceptibility of mitogen-responsive lymphocytes mediated by T cells.
    Kumar V; Caruso T; Bennett M
    J Exp Med; 1976 Apr; 143(4):728-40. PubMed ID: 1082914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Genovesi EV; Pettey CL; Collins JJ
    Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of in vitro generation of cytotoxic or T suppressor lymphocytes by Friend leukemia virus infection in mice.
    Garaci E; Migliorati G; Jezzi T; Bartocci A; Gioia L; Rinaldi C; Bonmassar E
    Int J Cancer; 1981 Sep; 28(3):367-73. PubMed ID: 6459295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of murine leukemia. VII. Prevention of Friend leukemia virus-induced immunosuppression by passive serum therapy.
    Genovesi EV; Livnat D; Collins JJ
    Int J Cancer; 1982 Nov; 30(5):609-24. PubMed ID: 6984021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemia virus-induced immunosuppression. X. Depression of T cell-mediated cytotoxicity after infection of mice with Friend leukemia virus.
    Mortensen RF; Ceglowski WS; Friedman H
    J Immunol; 1974 Jun; 112(6):2077-86. PubMed ID: 4207729
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the role of the host immune response in recovery from Friend virus leukemia. II. Cell-mediated immunity.
    Chesebro B; Wehrly K
    J Exp Med; 1976 Jan; 143(1):85-99. PubMed ID: 1081583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of lymphocytic subpopulations in Friend leukemia virus-induced leukemia.
    Kitagawa M; Matsubara O; Kasuga T
    Cancer Res; 1986 Jun; 46(6):3034-9. PubMed ID: 2870802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemia virus-induced immunosuppression: scanning electron microscopy of infected spleen cells.
    Farber P; Specter S; Friedman H
    Science; 1975 Oct; 190(4213):469-71. PubMed ID: 1166315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of the Friend leukemia virus on lymphocyte subpopulations in the mouse].
    Jezzi T; Premrov MG; Del Gobbo V; Garaci E
    Ann Ist Super Sanita; 1982; 18(3):513-5. PubMed ID: 6230037
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunosuppression in vitro induced by leukemia virus-infected splenocytes (38544).
    Kamo I; Kateley JR; Kaplan G; Friedman H
    Proc Soc Exp Biol Med; 1975 Feb; 148(2):383-6. PubMed ID: 1091933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to Friend leukemia virus in mice: effect of immunosuppression.
    Stutman O; Dupuy JM
    J Natl Cancer Inst; 1972 Nov; 49(5):1283-93. PubMed ID: 4405498
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of natural killer (nk) cell activity during FLV-P virus infection of mice.
    Migliorati G; Jezzi T; Frati L; Bonmassar E; Rossi GB; Garaci E; Riccardi C
    Int J Cancer; 1983 Jan; 31(1):81-90. PubMed ID: 6219962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scanning electron microscopy of antibody-dependent cell-mediated cytotoxicity of Friend leukemia virus-infected spleen cells.
    Farber PA; Friedman H
    Experientia; 1979 Jun; 35(6):832-3. PubMed ID: 288583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro depression of cellular immunity by Friend virus leukemic spleen cells.
    Toy ST; Whellock EF
    Cell Immunol; 1975 May; 17(1):57-73. PubMed ID: 1168547
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of antibody response helper factors in immunosuppressive effects of friend leukemia virus.
    Butler RC; Frier JM; Chapekar MS; Graham MO; Friedman H
    Infect Immun; 1983 Mar; 39(3):1260-4. PubMed ID: 6220970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.